Mucopolysaccharidoses and Other Lysosomal Storage Diseases
Authors:
- Christina LampeCLChristina Lampe
- Cinzia Maria BellettatoCBCinzia Maria Bellettato
- Nesrin KarabulNKNesrin Karabul
- Maurizio ScarpaMSMaurizio Scarpa
- 1 May 2013
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 39 (2) , 431-455
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I RegistryEuropean Journal of Pediatrics, 2012
- Glycosaminoglycan Storage Disorders: A ReviewBiochemistry Research International, 2011
- Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panelBMC Neurology, 2011
- Osteopenia in Gaucher disease develops early in life: Response to imiglucerase enzyme therapy in children, adolescents and adultsBlood Cells, Molecules, and Diseases, 2011
- Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type IIJournal of Inherited Metabolic Disease, 2010
- Hand and Foot Abnormalities Associated with Genetic DiseasesHAND, 2010
- Common and Uncommon Pathogenic Cascades in Lysosomal Storage DiseasesJournal of Biological Chemistry, 2010
- Involvement of the Toll-like receptor 4 pathway and use of TNF-α antagonists for treatment of the mucopolysaccharidosesProceedings of the National Academy of Sciences, 2009
- Pathogenic cascades in lysosomal disease—Why so complex?Journal of Inherited Metabolic Disease, 2009
- Farber disease: clinical presentation, pathogenesis and a new approach to treatmentPediatric Rheumatology, 2007